We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$577M
AUM Growth
+$117M
Cap. Flow
+$70.8M
Cap. Flow %
12.28%
Top 10 Hldgs %
35.5%
Holding
108
New
25
Increased
54
Reduced
16
Closed
13

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$14.9M
2
BDX icon
Becton Dickinson
BDX
+$11.1M
3
DHR icon
Danaher
DHR
+$10.9M
4
IMGN
Immunogen Inc
IMGN
+$9.93M
5
PODD icon
Insulet
PODD
+$8.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$10.2M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$10M
3
ELV icon
Elevance Health
ELV
+$9.95M
4
LLY icon
Eli Lilly
LLY
+$9.5M
5
IQV icon
IQVIA
IQV
+$9.08M

Sector Composition

Rank Sector Weight
1 Healthcare 98.94%
2 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
76
Aclaris Therapeutics
ACRS
$860M
$2.01M 0.35%
193,597
+27,577
+17% +$250K
MRNS
77
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.86M 0.32%
171,075
-78,925
-32% -$676K
ASLN
78
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.85M 0.32%
+63,328
New +$1.96M
MRUS
79
DELISTED
Merus
MRUS
$1.79M 0.31%
+67,881
New +$1.49M
GRTX
80
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.69M 0.29%
540,847
+15,847
+3% +$47.1K
AKRO
81
DELISTED
Akero Therapeutics
AKRO
$1.63M 0.28%
+35,000
New +$1.6M
MIRM icon
82
Mirum Pharmaceuticals
MIRM
$6.04B
$1.61M 0.28%
62,410
+292
+0.5% +$7.77K
TELA icon
83
TELA Bio
TELA
$32.3M
$1.61M 0.28%
159,026
+21,654
+16% +$221K
IMUX icon
84
Immunic
IMUX
$217M
$1.35M 0.23%
53,975
+7,998
+17% +$134K
QTRX icon
85
Quanterix
QTRX
$139M
$1.13M 0.2%
+50,144
New +$894K
SLN
86
Silence Therapeutics
SLN
$641M
$1.02M 0.18%
185,078
+26,304
+17% +$159K
INZY
87
DELISTED
Inozyme Pharma
INZY
$940K 0.16%
168,790
+43,790
+35% +$259K
TERN
88
DELISTED
Terns Pharmaceuticals
TERN
$896K 0.16%
102,425
+27,425
+37% +$320K
NSTG
89
DELISTED
NanoString Technologies, Inc.
NSTG
$759K 0.13%
+187,500
New +$1.38M
AFIB
90
DELISTED
Acutus Medical Inc
AFIB
$677K 0.12%
762,025
+108,304
+17% +$91.8K
VYGR icon
91
Voyager Therapeutics
VYGR
$197M
$663K 0.11%
+57,881
New +$599K
SVRA icon
92
Savara
SVRA
$1.17B
$660K 0.11%
206,607
+29,364
+17% +$69K
TKNO icon
93
Alpha Teknova
TKNO
$397M
$471K 0.08%
176,314
+25,059
+17% +$67.3K
MLYS icon
94
Mineralys Therapeutics
MLYS
$2.38B
$199K 0.03%
11,658
+1,658
+17% +$24.8K
CDTX
95
DELISTED
Cidara Therapeutics
CDTX
$154K 0.03%
6,801
-23,199
-77% -$545K
APLS
96
DELISTED
Apellis Pharmaceuticals
APLS
– –
-25,000
Closed -$1.65M
BIIB icon
97
Biogen
BIIB
$30.9B
– –
-17,920
Closed -$4.98M
ELV icon
98
Elevance Health
ELV
$86.6B
– –
-21,643
Closed -$9.95M
IQV icon
99
IQVIA
IQV
$39.8B
– –
-45,643
Closed -$9.08M
LEGN icon
100
Legend Biotech
LEGN
$3.99B
– –
-47,608
Closed -$2.3M
1 2 3
4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Parkman Healthcare Partners held 108 positions worth $577M, up 25% from $460M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners deployed $70.8M of net new capital in Q2 2023, opening 25 new positions and adding to 54 existing holdings. Its largest new stake was Cencora: 86,250 shares worth $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $10.2M trimmed.

  • Parkman Healthcare Partners's largest Q2 2023 buy was Cencora: 86,250 shares worth $16.6M.
  • Parkman Healthcare Partners added most to Becton Dickinson in Q2 2023, an estimated $11.1M increase.
  • Parkman Healthcare Partners's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $10.2M.
  • Parkman Healthcare Partners fully exited Elevance Health in Q2 2023, selling an estimated $9.95M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $577M portfolio in Q2 2023.
  • Parkman Healthcare Partners opened 25 new positions and closed 13 in Q2 2023.
  • Parkman Healthcare Partners's portfolio value rose 25% quarter-over-quarter to $577M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2023, filed 11 Aug 2023.